Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|October 29, 2004
Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor alphaBrett B Busch, William C Stevens, Richard Martin, et al.
Plant Physiology and Biochemistry : PPB|February 11, 2025
Sucrose synthase 3 improves fruit quality in grapeTing Huang, Ting Zheng, Pingjing Hong, et al.
European Journal of Medicinal Chemistry|November 2, 2018
Exploration of the carmaphycins as payloads in antibody drug conjugate anticancer agentsJehad Almaliti, Bailey Miller, Halina Pietraszkiewicz, et al.
Biotechnology and Bioengineering|October 16, 2021
Development of an E. coli strain for cell-free ADC manufacturingDan Groff, Nina A Carlos, Rishard Chen, et al.
Planta|February 25, 2025
Transcriptomic profiling reveals a regulatory network governing volatile compound biosynthesis in Shine Muscat grapes (Vitis labruscana Baily × V. vinifera L.)Yongkang Nong, Yanbei Chen, Yang Bai, et al.
Frontiers in Psychology|October 26, 2020
Altered Brain Functional Connectivity Density in Fast-Ball Sports Athletes With Early Stage of Motor TrainingChengbo Yang, Ning Luo, Minfeng Liang, et al.
Frontiers in Plant Science|February 10, 2023
Chromosome-scale genomics, metabolomics, and transcriptomics provide insight into the synthesis and regulation of phenols in <i>Vitis adenoclada</i> grapesGuo Cheng, Daidong Wu, Rongrong Guo, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2004
Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligandPatricia J Willy, Ian R Murray, Jing Qian, et al.
Molecular Cancer Therapeutics|October 31, 2015
Dual Agonist Surrobody Simultaneously Activates Death Receptors DR4 and DR5 to Induce Cancer Cell DeathSnezana Milutinovic, Arun K Kashyap, Teruki Yanagi, et al.
Molecular Cancer Therapeutics|April 28, 2025
The anti-FRα antibody-drug conjugate luveltamab tazevibulin demonstrates efficacy in non-small cell lung cancer preclinical models and induces immunogenic cell deathRobert Yuan, Andrew McGeehan, Sihong Zhou, et al.
Pageof 4